Skip to main content
. 2011 Dec 20;2(12):1109–1126. doi: 10.18632/oncotarget.380

Figure 9. Both mouse and human ATC cell lines are highly sensitive to glycolytic inhibitors.

Figure 9

(A) Top panel: dose-response curves showing the effect of 2-deoxyglucose (2-DG) on the viability of two mouse ATC cell lines. Middle panel: dose-response curves showing the. Bottom panel: isobolograms showing strong synergy between the two compounds. (B) Top panel: dose-response curves showing the cooperative effect of a 2-DG/Doxorubicin combination on the viability of two human ATC cell lines. Middle panel: isobolograms showing strong synergy between the two compounds. (C) Isobolograms showing strong synergy between doxorubicin and another glycolytic inhibitor, 3-bromopyruvate (3-BP).